Monitoring the treatment outcome in endometrial cancer patients by CEA and TATI

An attempt was made to compare the usefulness of determining markers carcinoembryonic antigen (CEA) and tumor-associated trypsin inhibitor (TATI) in endometrial cancer patients in whom recurrence or distant metastasis was diagnosed in observation after treatment. The study included 316 patients aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozakiewicz, Barbara, Chądzyńska, Małgorzata, Dmoch-Gajzlerska, Ewa, Stefaniak, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990607/
https://www.ncbi.nlm.nih.gov/pubmed/26779635
http://dx.doi.org/10.1007/s13277-016-4784-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990607/
https://www.ncbi.nlm.nih.gov/pubmed/26779635
http://dx.doi.org/10.1007/s13277-016-4784-9

Ejemplares similares